Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-030703
Filing Date
2025-08-13
Accepted
2025-08-13 08:04:33
Documents
15
Period of Report
2025-10-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20052685x1_pre14a.htm PRE 14A 901823
2 logo_bauschhealth1.jpg GRAPHIC 26150
3 logo_bauschhealth1x1.jpg GRAPHIC 15438
4 ny20052685x1_bcv1.jpg GRAPHIC 209405
5 ny20052685x1_cov1.jpg GRAPHIC 266963
6 ny20052685x1_cov2.jpg GRAPHIC 860183
7 ny20052685x1_email.jpg GRAPHIC 7213
8 ny20052685x1_fax.jpg GRAPHIC 6204
9 ny20052685x1_kingsdale.jpg GRAPHIC 32762
10 ny20052685x1_one.jpg GRAPHIC 7064
11 ny20052685x1_pc01.jpg GRAPHIC 687946
12 ny20052685x1_pc02.jpg GRAPHIC 795746
13 ny20052685x1_phone2.jpg GRAPHIC 36074
14 ny20052685x1_phone.jpg GRAPHIC 5404
15 ny20052685x1_two.jpg GRAPHIC 7355
  Complete submission text file 0001140361-25-030703.txt   4982400
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14956 | Film No.: 251209055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)